Skip to main content
An official website of the United States government
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

cord blood-derived expanded allogeneic natural killer cells

A preparation of human umbilical cord blood (UCB)-derived and ex vivo-expanded allogeneic natural killer (NK) cells, with immunomodulating and cytotoxic activities. Upon infusion of the cord blood-derived expanded allogeneic NK cells, these cells recognize and bind to tumor cells, and secrete perforins, granzymes, and cytokines, which cause cancer cell lysis.
Check for active clinical trials using this agentView this agent in the NCI Thesaurus
Synonym:allogeneic CB-derived ex vivo-expanded NK cells
CB-derived expanded allogeneic NK cells
UCB-derived expanded allogeneic NK cells
umbilical cord blood-derived expanded allogeneic natural killer cells
Search NCI's Drug Dictionary
Please enter up to 30 characters for your search